HIM
NGVT icon

Hillsdale Investment Management’s Ingevity NGVT Stock Holding History

Hillsdale Investment Management’s Portfolio NGVT Stock Details NGVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-100
Closed -$5.92K – 737
2025
Q4 		$5.92K Sell
100
-30
-23% -$1.63K ﹤0.01% 637
2025
Q3 		$7.17K Buy
+130
New +$6.76K ﹤0.01% 595
2023
Q1 		– Sell
-11,500
Closed -$810K – 622
2022
Q4 		$810K Buy
11,500
+500
+5% +$35.2K 0.07% 198
2022
Q3 		$667K Buy
+11,000
New +$738K 0.06% 252
2019
Q3 		– Sell
-7,000
Closed -$736K – 658
2019
Q2 		$736K Buy
7,000
+1,200
+21% +$121K 0.07% 263
2019
Q1 		$613K Buy
+5,800
New +$583K 0.06% 225

Other funds holding NGVT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
SCM
Simcoe Capital Management New York $576M AUM 36.22% 1-Year Est. Return

Hillsdale Investment Management's NGVT Position: Q1 2026 in Review

Hillsdale Investment Management sold out of Ingevity (NGVT) in Q1 2026, closing a stake of 100 shares — an estimated $5.92K sold.

Hillsdale Investment Management first reported a position in NGVT in Q1 2019 and held it in 6 quarters. The position peaked at $810K in Q4 2022. 307 funds tracked by Wall St. Rank hold NGVT as of Q1 2026.

  • Hillsdale Investment Management reported no remaining Ingevity position as of Q1 2026 after selling out during the quarter.
  • Hillsdale Investment Management sold 100 Ingevity shares in Q1 2026, an estimated $5.92K.
  • Hillsdale Investment Management first reported a position in Ingevity in Q1 2019 and held it in 6 quarters.
  • Hillsdale Investment Management's Ingevity position peaked at $810K in Q4 2022.
  • 307 funds tracked by Wall St. Rank held Ingevity as of Q1 2026.

Based on Hillsdale Investment Management's 13F filing for Q1 2026, filed 4 May 2026.